Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1999 1
2000 1
2001 1
2003 3
2004 1
2005 2
2006 8
2007 8
2008 5
2009 6
2010 5
2011 6
2012 6
2013 4
2014 7
2015 10
2016 5
2017 11
2018 8
2019 6
2020 7
2021 12
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

113 results
Results by year
Filters applied: . Clear all
Page 1
Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer.
Sarfaty M, Hall PS, Chan KKW, Virik K, Leshno M, Gordon N, Moore A, Neiman V, Rosenbaum E, Goldstein DA. Sarfaty M, et al. Among authors: leshno m. Eur Urol. 2018 Jul;74(1):57-62. doi: 10.1016/j.eururo.2018.03.006. Epub 2018 Mar 22. Eur Urol. 2018. PMID: 29576265 Free article.
113 results